Referred to the House Committee on Energy and Commerce.
The bill amends the Public Health Service Act to remove statutory liability protections that have limited civil lawsuits against vaccine manufacturers and administrators. It allows individuals to bring civil actions in state or federal court for vaccine-related injuries or deaths, makes related changes to filing deadlines and statutes of limitations, repeals certain program provisions tied to election and trial procedures, and adjusts related compensation and attorney-fee provisions in the National Vaccine Injury Compensation Program (NVICP).
Accountability vs public health tradeoff: conservatives emphasize restoring civil remedies and accountability; liberals emphasize risks to vaccine supply and emergency response.
Relative to its intended legislative type, this bill is a clearly targeted substantive statute-change that is drafted with high specificity in terms of which statutory provisions are altered, repealed, or redefined.
The bill amends the Public Health Service Act to remove statutory liability protections that have limited civil lawsuits against vaccine manufacturers and administrators.
It allows individuals to bring civil actions in state or federal court for vaccine-related injuries or deaths, makes related changes to filing deadlines and statutes of limitations, repeals certain program provisions tied to election and trial procedures, and adjusts related compensation and attorney-fee provisions in the National Vaccine Injury Compensation Program (NVICP).
The bill also specifically amends the definition of “covered countermeasure” so that COVID–19 vaccines are excluded from the liability protections in the countermeasure/declared-emergency framework.
On content alone, the bill represents a substantial rollback of federal vaccine liability protections in a politically charged policy area without compromise mechanisms or funding offsets. Such sweeping, controversial statutory reversals are difficult to enact through both chambers and to reconcile with stakeholder and public‑health concerns; therefore the content suggests a low probability of becoming law absent major changes, broad consensus, or a vehicle that bundles it with other bargaining items.
Relative to its intended legislative type, this bill is a clearly targeted substantive statute-change that is drafted with high specificity in terms of which statutory provisions are altered, repealed, or redefined. It creates a clear legal mechanism to allow civil actions and removes specified statutory immunities.
Accountability vs public health tradeoff: conservatives emphasize restoring civil remedies and accountability; liberals emphasize risks to vaccine supply and emergency response.
These are examples from the analysis, not a ranked list of the most-affected groups.
Accountability vs public health tradeoff: conservatives emphasize restoring civil remedies and accountability; liberals emphasize risks to vaccine supply and emergency response.
This persona would likely view the bill skeptically.
While sympathetic to individuals harmed by vaccines and supportive of compensation for legitimate injuries, they would be concerned that removing broad liability protections risks chilling vaccine research, increasing costs, and undermining public health programs and emergency responses.
They would want stronger safety nets for injured people without dismantling liability frameworks that have supported rapid vaccine development and distribution.
This persona would take a cautious, pragmatic stance.
They would see legitimate public interest in accountability for vaccine injuries but worry about unintended consequences for vaccine supply, costs, and emergency preparedness.
They would weigh the need to compensate injured individuals against maintaining incentives for manufacturers.
This persona would likely view the bill positively as restoring accountability and the rule of law for individuals harmed by vaccines, and as rolling back what they perceive as government or industry overreach that sheltered manufacturers from responsibility.
They would welcome the exclusion of COVID–19 vaccines from special countermeasure protections and see this as increasing transparency and civil remedies.
They would emphasize individual rights and market discipline over broad statutory immunity.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone, the bill represents a substantial rollback of federal vaccine liability protections in a politically charged policy area without compromise mechanisms or funding offsets. Such sweeping, controversial statutory reversals are difficult to enact through both chambers and to reconcile with stakeholder and public‑health concerns; therefore the content suggests a low probability of becoming law absent major changes, broad consensus, or a vehicle that bundles it with other bargaining items.
The bill has not accumulated any surfaced votes yet.
Accountability vs public health tradeoff: conservatives emphasize restoring civil remedies and accountability; liberals emphasize risks to…
On content alone, the bill represents a substantial rollback of federal vaccine liability protections in a politically charged policy area…
Relative to its intended legislative type, this bill is a clearly targeted substantive statute-change that is drafted with high specificity in terms of which statutory provisions are altered, repealed, or redefined. It…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.